QGel SA

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

QGel SA - overview

Established

2009

Location

Lausanne, -, Switzerland

Primary Industry

Biotechnology

About

QGel SA specializes in developing innovative biotechnological solutions to enhance agricultural productivity and sustainability through advanced biofertilizers and biopesticides. Founded in 2009 in Lausanne, Switzerland, QGel SA focuses on enhancing agricultural performance through its biotechnological innovations. The company was founded by Colin Sanctuary, who has a background in biotechnology. In December 2016, QGel SA raised USD 12 mn in venture financing from unspecified investors, effectively bringing its total funding to USD 12 mn.


The company has completed one deal to date, with its most recent funding round occurring in December 2016. QGel SA specializes in innovative biotechnological solutions aimed at enhancing agricultural productivity and sustainability. Their core product offerings include advanced biofertilizers and biopesticides designed to promote healthier crop growth while minimizing environmental impact. These products function by harnessing natural biological processes to improve soil health and increase crop resistance to pests and diseases.


The primary end users of these products are agricultural producers and farmers, particularly in regions such as North America, Europe, and parts of Asia, where there is a growing demand for eco-friendly agricultural practices. The company serves a diverse client base, including both large-scale agribusiness firms and smallholder farmers, addressing various agricultural needs across different geographical markets. QGel SA generates revenue through a structured model that primarily involves B2B transactions with agricultural producers and distributors. Their revenue streams are derived from the sale of proprietary biofertilizers and biopesticides, which are often offered through subscription plans for regular supply or as one-time purchases.


Partnerships with agricultural cooperatives and distribution networks further enhance the accessibility of their products. Pricing structures for these offerings are strategically set to reflect the value delivered through improved crop yields and sustainability benefits. QGel SA aims to expand its product line with several new biofertilizers and biopesticides in development, targeting a launch within the next two years. The company also plans to penetrate new markets in South America and Africa by 2025, responding to the increasing global demand for sustainable agriculture solutions.


Recent funding of USD 12 mn from December 2016 will support these initiatives, facilitating product development and market entry efforts.


Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment

Website

www.qgelbio.com

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.